These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 17892034

  • 1. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J.
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [Abstract] [Full Text] [Related]

  • 2. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K, Rogatko I, Milewicz T, Józef K, Tomasik PJ, Szafran Z.
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [Abstract] [Full Text] [Related]

  • 3. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [Abstract] [Full Text] [Related]

  • 4. 1 and 2 mg 17beta-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women.
    Stevenson JC, Rioux JE, Komer L, Gelfand M.
    Climacteric; 2005 Dec; 8(4):352-9. PubMed ID: 16390770
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N.
    Menopause; 2003 Dec; 10(4):286-91. PubMed ID: 12851511
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC.
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 8. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 9. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G, Falaschi P, Capri O, Pastore R, Galoppi P, D'Urso R, Martocchia A, Anelli G, Zichella L.
    Int J Fertil Menopausal Stud; 1994 Jul; 39(4):202-7. PubMed ID: 7951402
    [Abstract] [Full Text] [Related]

  • 10. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 11. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
    Hänggi W, Birkhäuser MH, Malek A, Peheim E, von Hospenthal JU.
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
    [Abstract] [Full Text] [Related]

  • 12. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 13. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Dec; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 14. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
    Prázný M, Fait T, Vrablik M.
    Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
    [Abstract] [Full Text] [Related]

  • 15. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P.
    Menopause; 2003 Aug; 10(6):550-8. PubMed ID: 14627865
    [Abstract] [Full Text] [Related]

  • 16. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 17. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M, Karakoç B, Gürler A.
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [Abstract] [Full Text] [Related]

  • 18. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J, Travica S, Metka M, Pietschmann P.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1035-43. PubMed ID: 10677891
    [Abstract] [Full Text] [Related]

  • 19. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B.
    Maturitas; 2005 Apr 11; 50(4):289-93. PubMed ID: 15780528
    [Abstract] [Full Text] [Related]

  • 20. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M, Kenemans P, de Bie L, van de Weijer PH, van der Mooren MJ.
    Fertil Steril; 2006 Apr 11; 85(4):979-88. PubMed ID: 16580384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.